September 2020 Quarter (Q1 FY21) Activities and Cash Flow Report Oct 15, 2020 ASX News Send Share Share
Incannex expands IHL-675A indications to include COPD, asthma, bronchitis, and other inflammatory lung conditions – after receiving positive results from additional in vivo studies Feb 4, 2021 | ASX News, Incannex Healthcare (ASX:IHL)